share_log

SELLAS Life Sciences Gr Analyst Ratings

Benzinga ·  Sep 8, 2023 00:00
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/07/2023 109.79% Cantor Fitzgerald → $3 Reiterates Overweight → Overweight
11/15/2022 459.44% Alliance Global Partners $14 → $8 Maintains Buy
06/28/2022 319.58% Cantor Fitzgerald $10 → $6 Maintains Overweight
07/21/2021 1158.74% Cantor Fitzgerald → $18 Initiates Coverage On → Overweight
11/15/2019 739.16% Maxim Group → $12 Upgrades Hold → Buy
04/08/2019 214.69% Alliance Global Partners → $4.5 Initiates Coverage On → Buy
11/01/2018 809.09% Oppenheimer → $13 Initiates Coverage On → Outperform

What is the target price for SELLAS Life Sciences Gr (SLS)?

The latest price target for SELLAS Life Sciences Gr (NASDAQ: SLS) was reported by Cantor Fitzgerald on September 7, 2023. The analyst firm set a price target for $3.00 expecting SLS to rise to within 12 months (a possible 109.79% upside). 2 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for SELLAS Life Sciences Gr (SLS)?

The latest analyst rating for SELLAS Life Sciences Gr (NASDAQ: SLS) was provided by Cantor Fitzgerald, and SELLAS Life Sciences Gr reiterated their overweight rating.

When is the next analyst rating going to be posted or updated for SELLAS Life Sciences Gr (SLS)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SELLAS Life Sciences Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SELLAS Life Sciences Gr was filed on September 7, 2023 so you should expect the next rating to be made available sometime around September 7, 2024.

Is the Analyst Rating SELLAS Life Sciences Gr (SLS) correct?

While ratings are subjective and will change, the latest SELLAS Life Sciences Gr (SLS) rating was a reiterated with a price target of $0.00 to $3.00. The current price SELLAS Life Sciences Gr (SLS) is trading at is $1.43, which is within the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment